NCCN Guidelines® Insights: Bladder cancer, version 3.2024: Featured Updates to the NCCN Guidelines Guidelines


Authors: Flaig, T. W.; Spiess, P. E.; Abern, M.; Agarwal, N.; Bangs, R.; Buyyounouski, M. K.; Chan, K.; Chang, S. S.; Chang, P.; Friedlander, T.; Greenberg, R. E.; Guru, K. A.; Herr, H. W.; Hoffman-Censits, J.; Kaimakliotis, H.; Kishan, A. U.; Kundu, S.; Lele, S. M.; Mamtani, R.; Mian, O. Y.; Michalski, J.; Montgomery, J. S.; Parikh, M.; Patterson, A.; Peyton, C.; Plimack, E. R.; Preston, M. A.; Richards, K.; Sexton, W. J.; Siefker-Radtke, A. O.; Stewart, T.; Sundi, D.; Tollefson, M.; Tward, J.; Wright, J. L.; Cassara, C. J.; Gurski, L. A.
Title: NCCN Guidelines® Insights: Bladder cancer, version 3.2024: Featured Updates to the NCCN Guidelines
Abstract: Bladder cancer, the sixth most common cancer in the United States, is most commonly of the urothelial carcinoma histologic subtype. The clinical spectrum of bladder cancer is divided into 3 categories that differ in prognosis, management, and therapeutic aims: (1) non–muscle-invasive bladder cancer (NMIBC); (2) muscle invasive, nonmetastatic disease; and (3) metastatic bladder cancer. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Bladder Cancer, including changes in the fifth edition of the WHO Classification of Tumours: Urinary and Male Genital Tumours and how the NCCN Guidelines aligned with these updates; new and emerging treatment options for bacillus Calmette-Guerin (BCG)–unresponsive NMIBC; and updates to systemic therapy recommendations for advanced or metastatic disease. © 2024 Harborside Press. All rights reserved.
Keywords: cancer staging; neoplasm staging; bcg vaccine; practice guideline; pathology; bladder tumor; urinary bladder neoplasms; humans; human; male
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 22
Issue: 4
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2024-05-01
Start Page: 216
End Page: 225
Language: English
DOI: 10.6004/jnccn.2024.0024
PUBMED: 38754471
PROVIDER: scopus
DOI/URL:
Notes: Article -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Harry W Herr
    594 Herr
Related MSK Work